INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/21/2024
Back to search
Official data from USPTO
FLUOROPASSIV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FLUOROPASSIV
ST13
US500000079189100Class
10
Filing
79189100
Registration
5135131
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/21/2024
Trademark type
Word
Nice classes
10
Filing date
03/31/2016
Registration date
02/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2023
Last transaction
08/18/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Renfrewshire PA4 9RR, GB
Examiner
VAGHANI, MAYUR C
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vascutek Limited
Representatives
JEFFREY H. GREGER ROBERTSMLOTKOWSKISAFRANCOLE&CALDERONPC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stentsvascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissuecardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; implantable medical systemscardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic vascular graftsprosthetic endovascular graftscatheters; implantable medical devicesimplants consisting of prosthetic materialssynthetic vascular prosthesesprosthetic vascular graftssynthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materialsprosthetic vascular graftsvascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular proceduresmedical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; thoracic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent graftsstent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent graftsmedical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent graftsstent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devicesaneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systemsprosthetic cardiac valves; heart valvesprosthetic heart valves; heart valve conduitscatheters for implanting heart valves; cardiac patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; vascular patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; thin wall carotid patchessurgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patchessurgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; knitted carotid patchessurgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patchessurgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/30/2024
INPC
INVALIDATION PROCESSED
04/30/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/18/2024
C71T
CANCELLED SECTION 71
08/18/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/24/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2017
FIMP
FINAL DISPOSITION PROCESSED
06/03/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2016
PUBO
PUBLISHED FOR OPPOSITION
11/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/17/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/13/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2016
ALIE
ASSIGNED TO LIE
09/17/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2016
RFNT
REFUSAL PROCESSED BY IB
08/05/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/20/2016
RFRR
REFUSAL PROCESSED BY MPU
07/20/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/20/2016
CNRT
NON-FINAL ACTION WRITTEN
07/19/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/19/2016
DOCK
ASSIGNED TO EXAMINER
07/15/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/14/2016
Continuous trademark protection
Get notified about every new filing that threatens FLUOROPASSIV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.